Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bas Groot Koerkamp

Showing results (161-170 of 486) with videos related to

Pageof 49
Sort By:
The British Journal of Surgery|February 19, 2025
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort studyEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Cancers|December 24, 2021
Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?Anne-Marleen van Keulen, Pim B Olthof, Matteo Cescon, et al.
Annals of Surgical Oncology|November 25, 2015
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control StudyEran Sadot, Diane L Reidy-Lagunes, Laura H Tang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 11, 2017
High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registryPim B Olthof, Robert J S Coelen, Jimme K Wiggers, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
The British Journal of Surgery|July 13, 2023
Prolonged antibiotic prophylaxis after pancreatoduodenectomy: systematic review and meta-analysisDaphne H M Droogh, Jesse V Groen, Mark G J de Boer, et al.
Liver Cancer|October 12, 2019
Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibTim A Labeur, Jeroen L A van Vugt, David W G Ten Cate, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 28, 2018
Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomyJony van Hilst, Matteo de Pastena, Thijs de Rooij, et al.
Surgery|March 20, 2021
The use and clinical outcome of total pancreatectomy in the United States, Germany, the Netherlands, and SwedenAnouk E J Latenstein, Tara M Mackay, Joal D Beane, et al.
United European Gastroenterology Journal|July 25, 2020
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tablesLianne Scholten, Anouk Ej Latenstein, Cora M Aalfs, et al.
Pageof 49

Showing results (161-170 of 486) with videos related to

Sort By:
Pageof 49
The British Journal of Surgery|February 19, 2025
Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort studyEsther N Dekker, David van Klaveren, Eva M M Verkolf, et al.
Cancers|December 24, 2021
Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?Anne-Marleen van Keulen, Pim B Olthof, Matteo Cescon, et al.
Annals of Surgical Oncology|November 25, 2015
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control StudyEran Sadot, Diane L Reidy-Lagunes, Laura H Tang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 11, 2017
High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registryPim B Olthof, Robert J S Coelen, Jimme K Wiggers, et al.
Annals of Surgical Oncology|January 3, 2024
Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium StudyDeesje Doppenberg, Thomas F Stoop, Susan van Dieren, et al.
The British Journal of Surgery|July 13, 2023
Prolonged antibiotic prophylaxis after pancreatoduodenectomy: systematic review and meta-analysisDaphne H M Droogh, Jesse V Groen, Mark G J de Boer, et al.
Liver Cancer|October 12, 2019
Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with SorafenibTim A Labeur, Jeroen L A van Vugt, David W G Ten Cate, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 28, 2018
Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomyJony van Hilst, Matteo de Pastena, Thijs de Rooij, et al.
Surgery|March 20, 2021
The use and clinical outcome of total pancreatectomy in the United States, Germany, the Netherlands, and SwedenAnouk E J Latenstein, Tara M Mackay, Joal D Beane, et al.
United European Gastroenterology Journal|July 25, 2020
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tablesLianne Scholten, Anouk Ej Latenstein, Cora M Aalfs, et al.
Pageof 49